Movatterモバイル変換


[0]ホーム

URL:


AU4197389A - In vivo infection of live insects with a recombinant baculovirus - Google Patents

In vivo infection of live insects with a recombinant baculovirus

Info

Publication number
AU4197389A
AU4197389AAU41973/89AAU4197389AAU4197389AAU 4197389 AAU4197389 AAU 4197389AAU 41973/89 AAU41973/89 AAU 41973/89AAU 4197389 AAU4197389 AAU 4197389AAU 4197389 AAU4197389 AAU 4197389A
Authority
AU
Australia
Prior art keywords
recombinant baculovirus
live insects
vivo infection
infection
vivo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41973/89A
Inventor
George Acs
Peter Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of MedicinefiledCriticalMount Sinai School of Medicine
Publication of AU4197389ApublicationCriticalpatent/AU4197389A/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU41973/89A1988-08-051989-08-04In vivo infection of live insects with a recombinant baculovirusAbandonedAU4197389A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US22915788A1988-08-051988-08-05
US2291571988-08-05

Publications (1)

Publication NumberPublication Date
AU4197389Atrue AU4197389A (en)1990-03-05

Family

ID=22860048

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU41973/89AAbandonedAU4197389A (en)1988-08-051989-08-04In vivo infection of live insects with a recombinant baculovirus

Country Status (2)

CountryLink
AU (1)AU4197389A (en)
WO (1)WO1990001556A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
ES2048646B1 (en)*1992-04-151994-10-01Ercros Sa PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)
US6090379A (en)*1992-04-292000-07-18Boyce Thompson Institute For Plant Research, Inc.Stable pre-occluded virus particle for use in recombinant protein production and pesticides
CA2133649C (en)*1992-04-291999-04-20H. Alan WoodOral infection of insect larvae with pre-occluded baculovirus particles
US5593669A (en)*1992-04-291997-01-14Boyce Thompson Institute For Plant Research, Inc.Stable pre-occluded virus particle
GB9924721D0 (en)1999-10-191999-12-22Craig RogerProtein production system
ATE299944T1 (en)*1999-10-192005-08-15Minos Biosystems Ltd SYSTEM FOR PRODUCING PROTEINS
AU2001273287A1 (en)*2000-07-132002-01-30The Curators Of The University Of MissouriLarge scale expression and purification of recombinant proteins
RU2239443C2 (en)*2002-05-272004-11-10Пятигорская государственная фармацевтическая академияDrone larva homogenate and lyophilizate eliciting hypolipidemic and hepatoprotective activity
AU2005211385B2 (en)2004-02-022008-12-11Ambrx, Inc.Modified human growth hormone polypeptides and their uses
RU2258522C1 (en)*2004-02-242005-08-20Федеральное государственное образовательное учреждение высшего профессионального образования Ставропольский государственный аграрный университетMethod for manufacturing a preparation for stimulating animal bodies out of drone bee larvae
BRPI0512235A (en)2004-06-182008-02-19Ambrx Inc antigen-binding polypeptides and their uses
MX2007000728A (en)2004-07-212007-03-15Ambrx IncBiosynthetic polypeptides utilizing non-naturally encoded amino acids.
SG161209A1 (en)2004-12-222010-05-27Ambrx IncFormulations of human growth hormone comprising a non-naturally encoded amino acid
EP1828224B1 (en)2004-12-222016-04-06Ambrx, Inc.Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
AU2005319518B2 (en)2004-12-222010-09-09Ambrx, Inc.Compositions of aminoacyl-tRNA synthetase and uses thereof
MX2007007591A (en)2004-12-222007-07-25Ambrx IncMethods for expression and purification of recombinant human growth hormone.
KR20070090023A (en)2004-12-222007-09-04암브룩스, 인코포레이티드Modified human growth hormone
CA2609205A1 (en)2005-06-032006-12-14Ambrx, Inc.Improved human interferon molecules and their uses
EP1937824B1 (en)2005-08-182013-03-13Ambrx, Inc.COMPOSITIONS OF tRNA AND USES THEREOF
US20090018029A1 (en)2005-11-162009-01-15Ambrx, Inc.Methods and Compositions Comprising Non-Natural Amino Acids
CA2663083A1 (en)2006-09-082008-03-13Ambrx, Inc.Modified human plasma polypeptide or fc scaffolds and their uses
MX2009002526A (en)2006-09-082009-04-16Ambrx IncSuppressor trna transcription in vertebrate cells.
US9133495B2 (en)2006-09-082015-09-15Ambrx, Inc.Hybrid suppressor tRNA for vertebrate cells
CN101121938B (en)*2007-03-232010-10-06中国农业科学院兰州兽医研究所Method for preparing foot-and-mouth disease antigen
ES2385114T3 (en)2007-03-302012-07-18Ambrx, Inc. Modified FGF-21 polypeptides and their uses
CA2685596A1 (en)2007-05-022008-11-13Ambrx, Inc.Modified interferon beta polypeptides and their uses
ES2632504T3 (en)2007-11-202017-09-13Ambrx, Inc. Modified insulin polypeptides and their uses
US9938333B2 (en)2008-02-082018-04-10Ambrx, Inc.Modified leptin polypeptides and their uses
EP2318029B1 (en)2008-07-232017-11-01Ambrx, Inc.Modified bovine g-csf polypeptides and their uses
NZ592250A (en)2008-09-262012-11-30Lilly Co EliModified animal erythropoietin polypeptides and their uses
MX357314B (en)2008-09-262018-07-04Ambrx IncNon-natural amino acid replication-dependent microorganisms and vaccines.
US20120283171A1 (en)2009-12-212012-11-08Ambrx, Inc.Modified bovine somatotropin polypeptides and their uses
US20120283172A1 (en)2009-12-212012-11-08Ambrx, Inc.Modified porcine somatotropin polypeptides and their uses
HUE045845T2 (en)2010-08-172021-12-28Ambrx Inc Modified relaxin polypeptides and their use
US9567386B2 (en)2010-08-172017-02-14Ambrx, Inc.Therapeutic uses of modified relaxin polypeptides
TWI480288B (en)2010-09-232015-04-11Lilly Co EliFormulations for bovine granulocyte colony stimulating factor and variants thereof
PE20170950A1 (en)2014-10-242017-07-13Bristol Myers Squibb Co MODIFIED FIBROBLAST GROWTH FACTOR 2 (FGF-21) POLYEPTIDES AND USES OF THE SAME
CA3052639A1 (en)2017-02-082018-08-16Bristol-Myers Squibb CompanyModified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0222412B1 (en)*1985-11-141992-11-19Daiichi Pharmaceutical Co., Ltd.Method of producing peptides
ES2008204A6 (en)*1986-09-091989-07-16Genetics InstMethod for producing a heterologous protein in insect cells.

Also Published As

Publication numberPublication date
WO1990001556A1 (en)1990-02-22

Similar Documents

PublicationPublication DateTitle
AU4197389A (en)In vivo infection of live insects with a recombinant baculovirus
AU1147988A (en)Improved disposable cup with an integrally formed straw
AU3026289A (en)Windrow merger
AU4088285A (en)A novel human physiologically active polypeptide
AU5615690A (en)Tines structure in clinical applicator
GB8828399D0 (en)Disposable covered needle assembly
AU2803392A (en)Disposable tissue retrieval assembly
NZ231803A (en)Transforming growth factor-beta2 and its preparation via recombinant techniques
AU6244090A (en)Improved surgical needle configuration with five-sided cross-section
AU7959187A (en)Insect repellant
AU3965089A (en)Plastic surgery implant
AU3228789A (en)Biologically active proteins
AU3501889A (en)Fishing lure
IL90690A0 (en)Tissue equivalents and their preparation
IL92359A0 (en)Zirconium oxide fibers and their preparation
AU5632090A (en)Fluorescent aquatic bioassay and procedure
AU3092989A (en)Illuminated fishing lure and battery therefor
GB8819541D0 (en)Insect repellent
GB8826104D0 (en)Phantom having similar optical characteristics to living tissue
AU4846090A (en)Single-use medical needle
AU635036B2 (en)Recombinant avipoxvirus
AU7082487A (en)Recombinant human b-cell growth factor
AU1821788A (en)Stabilized aqueous biocide composition incorporating a polymer and phthalate
EP0450100A4 (en)Physiologically active peptide
AU3705689A (en)Sialic acid-bonded octapeptide and preparation thereof

[8]ページ先頭

©2009-2025 Movatter.jp